Company Overview: SGYP

Upcoming Projects (SGYP)

Don’t see a project related to the company you care about? Create your own!

Executed Projects (SGYP)

Don’t see a project related to the company you care about? Create your own!

Upcoming & Overdue Catalysts (SGYP)

Don’t see a catalyst related to the company you care about? Create your own!

Occurred Catalysts (SGYP)

Ardelyx, Inc. Expected to Release Clinical Data by Late 2017 from T3MPO-2 Trial with Tenapanor in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Tickers: ARDX, SGYP, IRWD
Occurred on: Oct 16, 2017
Ardelyx, Inc. Expected to Release Clinical Data by Mid-2017 from T3MPO-1 Trial with Tenapanor in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)
Tickers: ARDX, SGYP, IRWD
Occurred on: May 12, 2017
Synergy Pharma (SGYP) Plans to Submit Supplemental New Drug Application (sNDA) for Plecanatide in Irritable Bowel Syndrome With Constipation (IBS-C) in Q1 2017
Ticker: SGYP
Occurred on: Mar 27, 2017
Synergy (SGYP) Announces Phase 3 Results Analyzing TRULANCE (Plecanatide) in Adults with Chronic Idiopathic Constipation (CIC) in the American Journal of Gastroenterology
Ticker: SGYP
Occurred on: Feb 07, 2017
Synergy Pharma (SGYP) PDUFA Date of January 29th, 2017 for Plecanatide in Chronic Idiopathic Constipation (CIC)
Ticker: SGYP
Occurred on: Jan 19, 2017
Synergy Pharma (SGYP) Presents Data from First Phase 3 Trial Evaluating Plecanatide in Irritable Bowel Syndrome with Constipation (IBS-C)
Ticker: SGYP
Occurred on: Dec 09, 2016
Synergy Pharma (SGYP) Presents New Long-Term Safety Data of Plecanatide in Chronic Idiopathic Constipation (CIC)
Ticker: SGYP
Occurred on: Oct 17, 2016
Synergy Pharmaceuticals Provides Update on Ongoing FDA Review of Plecanatide CIC NDA and IBS-C Clinical Development Program
Ticker: SGYP
Occurred on: Jul 15, 2016
Synergy Pharmaceuticals Presents New In Vitro Data Showing the pH-Dependent Activity of Plecanatide Replicates That of Naturally Occurring GI Peptide Uroguanylin
Ticker: SGYP
Occurred on: May 24, 2016
The First Phase 3 trial for Plecanatide in IBS-C read out
Tickers: SGYP, PFE, AGN, VRX, IRWD
Occurred on: May 22, 2016
Synergy Pharmaceuticals Presents Additional Phase 3 Plecanatide Data in Chronic Idiopathic Constipation at Digestive Disease Week
Ticker: SGYP
Occurred on: May 21, 2016
Synergy Pharmaceuticals Files New Drug Application for Plecanatide in Chronic Idiopathic Constipation
Ticker: SGYP
Occurred on: Jan 29, 2016

Strategic Initiatives (SGYP)

Don’t see a strategic initiative related to the company you care about? Create your own!

SGYP Overview